pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
omeicos PRESS RELEASE ARCHIVE
Sep 3, 2019
OMEICOS Therapeutics Appoints Dr Simon Russell as Chief Business Officer
Apr 29, 2019
OMEICOS Therapeutics Announces First-Dosing in Phase 2 Clinical Study Evaluating its Lead Program OMT-28 in Patients with Persistent Atrial Fibrillation
Feb 11, 2019
OMEICOS Therapeutics Strengthens Board of Directors with the Appointment of Christian Schetter
Nov 2, 2018
OMEICOS Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation
Nov 2, 2018
Forbion Leads €17M Series C Financing of Omeicos Therapeutics
Jul 17, 2018
OMEICOS Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation
Apr 27, 2018
Alexander Gebauer Joins Executive Board of OMEICOS Therapeutics and Named CEO and Chairman of OMEICOS Ophthalmics
Nov 13, 2017
OMEICOS Announces Formation of Inaugural Clinical Advisory Board
Oct 4, 2017
OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology
Jun 7, 2017
OMEICOS Secures Continued BMBF Support with New €1.7M Research Grant to Advance its Novel Approach to Treat Cardiovascular Diseases
Mar 1, 2017
OMEICOS Announces First Closing of €8.3 Million Series B Financing Round and the Initiation of Phase 1 Clinical Trial
Nov 2, 2015
OMEICOS Receives BMBF Research Grant to Advance its Novel Approach to Treat Atrial Fibrillation
May 5, 2015
OMEICOS Appoints Dr. Ulrich Dauer as Chief Executive Officer
Apr 15, 2015
OMEICOS Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation
